HongZhang BeijingChina

Wcn26 Post edited Speaker Card

https://storage.unitedwebnetwork.com/files/486/777412-35623-Hong Zhang_363132.png

Time	Session

9:25 a.m. 10:55 a.m.	B Cell Targeting in Glomerular Disease SK YusukeSuzuki Moderator Japan A Role for Kidney Resident B/plasma Cells in Kidney Disease Progression? HeatherReich Speaker Canada B Cell Activating Factor and A Proliferation-inducing Ligand Signaling in Glomerular Disease HongZhang Speaker China B Cell Targeted Therapies in Glomerular Diseases RichardLafayette Speaker United States The Future of B Cell Therapies in the Treatment of Glomerular Diseases Jonathan Barratt Speaker United Kingdom Q&A Session 503
5 p.m. 6 p.m.	Industry Symposium 26 YusukeSuzuki Moderator Japan Evolving Landscape of IgA Nephropathy in 2026 and Beyond HongZhang Speaker China 303

Time	Session

12:50 p.m. 1:50 p.m.	Industry Symposium 47 BradRovin Moderator United States Intro + IgAN Case: Global Perspective BradRovin Speaker United States IgAN Case: China Perspective HongZhang Speaker China IgAN Case: Japan Perspective HITOSHISUZUKI Speaker Japan 301 - 302
2:10 p.m. 3:10 p.m.	Hot Debate: Complement Inhibition vs Nefecon in IgA Nephropathy – Which First for Patients at Risk? BKH Magdalena Madero Moderator Mexico Complement Inhibition Should Be Considered Before Nefecon in Patients With IgAN at Risk of Progression VladoPerkovic Speaker Australia Nefecon Should Be Considered Before Complement Inhibition in Patients With IgAN at Risk of Progression HongZhang Speaker China 501 - 502